Standard protocol approvals, registrations, and patient consents
MAY
The study protocol and informed consent were approved by a central institutional review board (Advarra, Columbia, MD, USA). All participants provided informed consent. The trial was preregistered (ClinicalTrials.gov number, NCT04874155) on May 5, 2021.